Geode Capital Management’s Immunoprecise Antibodies IPA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,668
| Closed | -$4.02K | – | 4484 |
|
|
2025
Q1 | $4.02K | Hold |
10,668
| – | – | ﹤0.01% | 4461 |
|
|
2024
Q4 | $4.39K | Sell |
10,668
-6,816
| -39% | -$2.81K | ﹤0.01% | 4464 |
|
|
2024
Q3 | $11.2K | Hold |
17,484
| – | – | ﹤0.01% | 4462 |
|
|
2024
Q2 | $17.7K | Hold |
17,484
| – | – | ﹤0.01% | 4473 |
|
|
2024
Q1 | $26.6K | Hold |
17,484
| – | – | ﹤0.01% | 4438 |
|
|
2023
Q4 | $29.9K | Hold |
17,484
| – | – | ﹤0.01% | 4451 |
|
|
2023
Q3 | $32K | Hold |
17,484
| – | – | ﹤0.01% | 4528 |
|
|
2023
Q2 | $51.8K | Hold |
17,484
| – | – | ﹤0.01% | 4498 |
|
|
2023
Q1 | $48.4K | Hold |
17,484
| – | – | ﹤0.01% | 4528 |
|
|
2022
Q4 | $92K | Hold |
17,484
| – | – | ﹤0.01% | 4426 |
|
|
2022
Q3 | $69K | Hold |
17,484
| – | – | ﹤0.01% | 4693 |
|
|
2022
Q2 | $67K | Hold |
17,484
| – | – | ﹤0.01% | 4704 |
|
|
2022
Q1 | $89K | Hold |
17,484
| – | – | ﹤0.01% | 4695 |
|
|
2021
Q4 | $93K | Buy |
17,484
+2,988
| +21% | +$15.9K | ﹤0.01% | 4752 |
|
|
2021
Q3 | $90K | Buy |
+14,496
| New | +$90K | ﹤0.01% | 4699 |
|